B. Calingaert

First name
B.
Last name
Calingaert
Johannes, C. B., Beachler, D. C., Layton, J. B., Danysh, H. E., Ziemiecki, R., Arana, A., et al. (2022). Post-Authorization Safety Study of Hospitalization for Acute Kidney Injury in Patients with Type 2 Diabetes Exposed to Dapagliflozin in a Real-World Setting. Drug Saf. http://doi.org/10.1007/s40264-022-01263-3
View
Danysh, H. E., Johannes, C. B., Beachler, D. C., Layton, J. B., Ziemiecki, R., Arana, A., et al. (2022). Post-Authorization Safety Studies of Acute Liver Injury and Severe Complications of Urinary Tract Infection in Patients with Type 2 Diabetes Exposed to Dapagliflozin in a Real-World Setting. Drug Saf. http://doi.org/10.1007/s40264-022-01262-4
View
Margulis, A. V., Fortuny, J., Kaye, J. A., Calingaert, B., Reynolds, M., Plana, E., et al. (2018). Value of Free-text Comments for Validating Cancer Cases Using Primary-care Data in the United Kingdom. Epidemiology. http://doi.org/10.1097/ede.0000000000000856
View
Kuiper, J. G., van Herk-Sukel, M. P. P., Castellsague, J., Pottegard, A., Berglind, I. A., Dedman, D., et al. (2018). Use of Topical Tacrolimus and Topical Pimecrolimus in Four European Countries: A Multicentre Database Cohort Study. Drugs Real World Outcomes. http://doi.org/10.1007/s40801-018-0133-1
View
Margulis, A. V., Fortuny, J., Kaye, J. A., Calingaert, B., Reynolds, M., Plana, E., et al. (2018). Validation of Cancer Cases Using Primary Care, Cancer Registry, and Hospitalization Data in the United Kingdom. Epidemiology. http://doi.org/10.1097/ede.0000000000000786
View
Castellsague, J., Kuiper, J. G., Pottegard, A., Berglind, A., Dedman, D., Gutierrez, L., et al. (2018). A cohort study on the risk of lymphoma and skin cancer in users of topical tacrolimus, pimecrolimus, and corticosteroids (Joint European Longitudinal Lymphoma and Skin Cancer Evaluation - JOELLE study). Clin Epidemiol. http://doi.org/10.2147/clep.s146442
View
Arana, A., Pottegard, A., Kuiper, J. G., Booth, H., Reutfors, J., Calingaert, B., et al. (2021). Long-Term Risk of Skin Cancer and Lymphoma in Users of Topical Tacrolimus and Pimecrolimus: Final Results from the Extension of the Cohort Study Protopic Joint European Longitudinal Lymphoma and Skin Cancer Evaluation (JOELLE). Clinical Epidemiology. http://doi.org/https://doi.org/10.2147/CLEP.S331287
View